Johnson & Johnson Innovation – JJDC logo

Johnson & Johnson Innovation – JJDC

North America, Massachusetts, United States, Cambridge

Description

JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.

Investor Profile

Johnson & Johnson Innovation – JJDC has made 99 investments, with 14 in the past 12 months and 29% as lead.

Stage Focus

  • Series A (27%)
  • Series B (23%)
  • Series C (18%)
  • Series Unknown (7%)
  • Series D (6%)
  • Post Ipo Equity (6%)
  • Seed (5%)
  • Series E (2%)
  • Grant (2%)
  • Private Equity (1%)

Country Focus

  • United States (67%)
  • Israel (7%)
  • United Kingdom (6%)
  • France (5%)
  • Switzerland (3%)
  • The Netherlands (3%)
  • China (2%)
  • Belgium (2%)
  • Canada (1%)
  • Australia (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Therapeutics
  • Pharmaceutical
  • Health Diagnostics
  • Life Science
  • Biopharma
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Johnson & Johnson Innovation – JJDC frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 6
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 8
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 8
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 10
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 8
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 6
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 5
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6

Which angels does Johnson & Johnson Innovation – JJDC often collaborate with?

Shared Deals: 1
RS
North America, California, United States, San Francisco
Shared Deals: 1
ZW
North America, New York, United States, New York
Shared Deals: 1
NT
North America, New York, United States, New York
Shared Deals: 1
MB
North America, California, United States, San Francisco
Shared Deals: 2
RH
North America, Ohio, United States, Toledo
Shared Deals: 1
BB
North America, California, United States, San Francisco
Shared Deals: 1
LS
North America, Illinois, United States, Chicago
Shared Deals: 1

What are some of recent deals done by Johnson & Johnson Innovation – JJDC?

Perceive Pharma

San Francisco, California, United States

Perceive Pharma operates as a pharmaceutical company.

PharmaceuticalTherapeutics
Series AFeb 18, 2025
Amount Raised: $15,000,000
TECLens

New York, New York, United States

TECLens develops technology to treat keratoconus and correct vision problems.

Health CareMedical Device
Series AFeb 11, 2025
Amount Raised: $9,300,000
Citryll

Oss, Noord-Brabant, The Netherlands

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

BiopharmaBiotechnologyMedicalMedical DeviceNeuroscience
Series BDec 9, 2024
Amount Raised: $89,720,936
Cala Health

San Mateo, California, United States

Cala Health is a bioelectronic medicine company that develops wearable neuromodulation devices for the treatment of chronic diseases.

Health CareMedicalMedical DeviceWearables
Series CDec 9, 2024
Amount Raised: $50,000,000
G.I. Windows

Westwood, Massachusetts, United States

G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.

BiotechnologyDiabetesHealth CareMedical Device
Series BNov 20, 2024
Amount Raised: $37,000,000
TRex Bio

South San Francisco, California, United States

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

BioinformaticsBiopharmaBiotechnology
Series BNov 13, 2024
Amount Raised: $84,000,000
Orasis Pharmaceuticals

Ponte Vedra, Florida, United States

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company that develops eye drops for the treatment of presbyopia.

Clinical TrialsHealth CareMedicalPharmaceutical
Series DOct 8, 2024
Amount Raised: $68,000,000
ONL Therapeutics

Ann Arbor, Michigan, United States

ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DSep 13, 2024
Amount Raised: $65,000,000
Spectrawave

Waltham, Massachusetts, United States

Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.

BiotechnologyHealth CareHealth DiagnosticsMedicalMedical Device
Series BSep 11, 2024
Amount Raised: $50,000,000
HistoSonics

Plymouth, Minnesota, United States

HistoSonics specializes in developing non-invasive medical devices, interventional radiology, and surgical robotics.

Health CareMedicalMedical Device
Series DAug 15, 2024
Amount Raised: $102,000,000